clinical trial · NCT06408935
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
Crohn's DiseaseGuselkumab
brief summary
The purpose of this study is to evaluate the efficacy of guselkumab in healing of all layers of the digestive tract (transmural healing) with the help of a score called Magnetic Resonance Index of Activity (MaRIA) based on a scan at Week 48.
started
Apr 17, 2024
primary completion
Jun 8, 2027
completion
Mar 6, 2028
last updated
May 8, 2026
official title
A Phase 3b, Open-label, Multicenter Study to Evaluate Transmural Healing and Disease Modifying Effect of Guselkumab in Crohn's Disease Patients
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol